Marijuana and hemp companies keen to participate in Mexico’s emerging medical cannabis program should start preparing now, attorney advise, noting it will give businesses a leg up in entering the nation’s adult-use industry once it launches.
The market for buying and selling licensed cannabis businesses has perhaps never been hotter, with demand fueled by new entrants into the industry, hopes for federal marijuana reform and multistate operators keen to expand their footprint.
California has a reputation for heavily regulating businesses, and the marijuana industry is no exception. As of Jan. 1, a mandate requires all marijuana products to be labeled with warnings about the health dangers of both marijuana smoke and THC.
On December 17, the Federal Trade Commission (FTC) announced its first crackdown on deceptive marketing claims for CBD products. These claims cover a range of scientifically unsupported benefits, including cancer, heart disease, hypertension, and Alzheimer’s disease, and also include allegations that at least one company made false claims about scientific findings.
California lawmakers will be faced again with the long-debated question of whether to allow hemp extracts in food and beverages in the state when the legislative session opens Monday.
Health warning labels will be required for all cannabis products sold in California starting Jan. 3, a mandate that will likely create a wave of new product-liability lawsuits targeting marijuana and hemp companies, industry attorneys predicted.
